IL-1 is a pro-in¯ammatory cytokine consisted of two molecular species, IL-1a and IL-1b, and the IL-1 receptor antagonist (IL-1Ra) is a natural inhibitor of both molecules. Although it is suggested that IL-1 potentiates immune responses mediated by T h 2 cells, the role of IL-1 in asthma still remains unclear. In this study, we demonstrate that the ovalbumin (OVA)-induced airway hypersensitivity response (AHR) in IL-1a/b-de®cient (IL-1a/b ±/± ) mice was signi®cantly reduced from the levels seen in wild-type mice, whereas the responses seen in IL-1Ra ±/± mice were profoundly exacerbated, suggesting that IL-1 is required for T h 2 cell activation during AHR. OVA-speci®c T cell proliferation, IL-4 and IL-5 production by T cells, and IgG1 and IgE production by B cells in IL-1a/b ±/± mice were markedly reduced compared with these responses in wild-type mice; such responses were enhanced in IL-1Ra ±/± mice. Using IL-1a ±/± and IL-1b ±/± mice, we determined that both IL-1a and IL-1b are involved in this reaction. Both IgG1 and IgE levels were reduced in IL-1b ±/± mice, while only IgE levels were affected in IL-1a ±/± mice, indicating a functional difference between IL-1a and IL-1b. These observations indicate that IL-1 plays important roles in the development of AHR.
Introduction
Allergic asthma is a T h 2 cytokine-mediated in¯ammatory response of the lungs characterized by mucus hypersecretion, airway in¯ammation and airway hyper-responsiveness to spasmogenic stimuli (1) . In cases of asthma presenting with lung in¯ammation, the in®ltration of eosinophils is predominant; the degree of in®ltration correlates with illness severity (2) . T cells, B cells and mast cells are also involved in the development of the allergic response, acting through the release of cytokines, antibodies and in¯ammatory mediators (1, 3) .
Allergen-speci®c T h 2 cells function in the development of AHR by secreting cytokines, including IL-4, IL-5 and IL-13 (1) . IL-4 and IL-13 are required for AHR induction through inducing allergen-speci®c IgG1 and IgE production (4), resulting in the activation of mast cells via antigen/antibody complex±Fc receptor signaling (5) , while IL-5 demonstrates a critical role in eosinophilia (4, 6) . Activated mast cells produce IL-4, IL-5, tumor necrosis factor (TNF)-a and various in¯ammatory mediators within the in¯ammatory site (5) . IL-4 and TNF-a can induce vascular cell adhesion molecule (VCAM)-1 expression on endothelial cells, leading to the adhesion of various in¯ammatory cells to local in¯ammatory sites (7, 8) .
IL-1, a pro-in¯ammatory cytokine involved in a variety of immune responses, can promote mast cell activation and production of T h 2 cytokines (9, 10) , suggesting that IL-1 functions in the development of allergic diseases. It is also known that IL-1 is a potent inducer of VCAM-1 on vascular endothelial cells (11±13) and mice lacking the type I IL-1 receptor (IL-1RI ±/± mice) exhibit reduced eosinophil recruitment into the lungs due to the decreased expression of VCAM-1 during antigen-induced AHR (14) . Furthermore, IL-1 can activate T h 2 cells and enhance antibody production (15±20). The involvement of IL-1 in asthmatic diseases that are mediated by T h 2 cells, however, remains unclear. It is also unknown if either IL-1a or IL-1b or both are necessary for AHR development. In this study, we demonstrate that IL-1 is required for allergen-speci®c T h 2 cell activation and that both IL-1a and IL-1b function in the development of AHR.
Methods

Mice
IL-1a ±/± , IL-1b ±/± , IL-1a/b ±/± and IL-1Ra ±/± mice were generated by homologous recombination as described, then backcrossed to BALB/cA mice for eight generations (21) . DO11.10 Tg mice (BALB/c background) were kindly provided by Dr Dennis Y. Loh (22) . All mice were housed under speci®c pathogen-free conditions in an environmentally controlled clean room at the Center for Experimental Medicine, Institute of Medical Science, University of Tokyo. All experiments were conducted according to the institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation. Sex-and age-matched adult mice aged 8±12 weeks old were used for experimentation.
Ovalbumin (OVA)/alum-induced airway hypersensitivity
Mice were actively sensitized by i.p. injection of 100 mg of OVA with aluminum potassium sulfate (alum) on days 0 and 14. They were challenged intranasally by 100 mg of OVA in 50 ml saline, using a microsyringe, on days 14, 21, 24 and 27. Shamsensitized mice were treated with i.p. injections of alum precipitated with saline alone and intranasal doses of saline alone. Twenty-four hours after the last intranasal administration of OVA, mice were anesthetized with pentobarbital (80 mg/kg, i.p.) and i.v. access was established by cannulating the jugular vein. The trachea was cannulated and connected to a rodent ventilator (model 687; Harvard Apparatus, South Natick, MA) with air supplemented at a tidal volume of 100.8 T 3.3 ml/10 g body wt (n = 24), frequency of 100 breaths/min and positive end-expiratory pressure of 3 cmH 2 O. After neuromuscular blockade with gallamine triethiodide (10 mg/ kg, i.v.), bronchoconstriction was measured according to the over¯ow method, using a pressure transducer (7020; Ugo Basile, Milan, Italy) connected to the tracheal cannula. To assess the bronchial responsiveness to i.v. injected acetylcholine (ACh), the changes in the respiratory over¯ow volume were measured using progressively increasing doses of ACh. The increase in respiratory over¯ow volume provoked by ACh was represented as a percentage of the maximal over¯ow volume (100%) obtained by clamping the tracheal cannula.
OVA/PBS-induced airway hypersensitivity
OVA immunization without alum was performed as described previously (23, 24) . Brie¯y, mice were i.p. injected with 10 mg of OVA (grade II; Sigma, St Louis, MO) in 0.5 ml of PBS on each of 7 alternate days (one injection per day). Four weeks after the ®nal immunization, mice were challenged intranasally 8 times for 8 days (one challenge per day) with 20 ml of either PBS alone as a control or PBS containing 100 mg of OVA. AHR to methacholine was assessed using the parameter P enh (enhanced pause), which is calculated automatically based on the mean pressure generated in plethysmograph chambers during inspiration and expiration with the Buxco system as described elsewhere (25) . Twenty-four hours following the last inhalation of OVA, bronchial responses to aerosolized methacholine (Sigma) were measured using the Buxco system (Buxco Electronics, Sharon, CT).
OVA-speci®c T cell proliferation assay
To measure secondary T cell responses, submaxillary lymph nodes (LN) were harvested 24 h after the last challenge with OVA. Single-cell suspensions prepared from these samples were cultured in a 96-well¯at-bottom plate at a concentration of 5 Q 10 4 cells/well in the absence or presence of 40 mg/ml OVA for 72 h. The primary T cell response was measured using DO11.10 CD4 + T cells as described previously (26) . The CD4 + T cells from DO11.10 Tg mice (5 Q 10 5 cells/well) and Thy1.2 ± B220 ± splenic adherent cells (1 Q 10 4 cells/well) from either wild-type or IL-1-de®cient mice were cultured in the absence or presence of 0.1 mM OVA323±339 peptide for 72 h. Next, [ 3 H]thymidine (0.25 mCi/ml) (Amersham, Little Chalfont, UK) was added to the culture. After a 6-h label, the cells were harvested using a Micro 96 cell harvester (Skatron, Lier, Norway). Incorporated [ 3 H]thymidine was measured using the Micro Beta System (Pharmacia Biotech, Piscataway, NJ).
Detection of cytokine by ELISA
The Mini Kit mouse IL-4 kit (Endogen, Woburn, MA) for IL-4 and Titer Zyme EIA kit (PerSeptive Diagnostics, Cambridge, MA) for IL-5 were used to determine the cytokine levels according to the manufacturer's protocol.
Detection of serum Ig
To detect either OVA-speci®c or total Ig levels by ELISA, 50 ml of either 10 mg/ml OVA or 10 mg/ml rabbit anti-mouse Ig (Dako, Glostrup, Denmark) was coated onto 96-well¯at-bottom plates. Following blocking with 0.05% skim milk in PBS for 1 h, 50 ml of the test samples was added to each well. After extensive washing, 50 ml of either alkaline phosphatase±goat anti-mouse IgG1 (Zymed, San Francisco, CA) or alkaline phosphatase±rat anti-mouse IgE (Southern Biotechnology Associates, Birmingham AL) was added to visualize bound antibodies. Alkaline phosphatase activity was measured using Substrate Phosphatase SIGMA104 (Sigma).
Statistics
Student's t-test was used for the statistical evaluation of the results.
Results
Involvement of IL-1 in AHR
Although eosinophil in®ltration into the lungs decreases in IL-1RI ±/± mice on a 129 Q B6 background (14) , the involvement of IL-1 in the development of AHR remained to be studied. Thus, to determine whether IL-1 is necessary for the induction of AHR, we examined the role of IL-1 in this response using IL-1a/ b ±/± mice on a BALB/cA background following sensitization to OVA. First, we examined AHR induced by OVA/alum. Upon sensitization with OVA/alum, AHR in response to methacholine stimulation was not different between wild-type and IL-1a/b ±/± mice ( Fig. 1 ). Moreover, mutant mice immunized with OVA/ alum exhibited a similar level of eosinophil in®ltration into the lungs and similar IgE levels in sera as wild-type mice (data not shown).
Since we previously experienced that the function of IL-1 in the humoral immune response was substituted by other cytokines in the presence of adjuvant (18), we next examined AHR induced by OVA in the absence of alum. Twenty-four hours after the ®nal OVA inhalation, AHR to methacholine in IL-1a/b ±/± mice was signi®cantly reduced compared with that observed in wild-type mice (Fig. 2) . Consistent with the reduced AHR in IL-1a/b ±/± mice, the number of lung-in®ltrating cells in IL-1a/b ±/± mice as revealed by the histology following OVA inhalation was less than that seen for wild-type mice (data not shown). The total cell numbers in the bronchoalveolar lavage of IL-1a/b ±/± mice were decreased compared with that in wild-type mice (data not shown).
On the other hand, AHR to methacholine in IL-1Ra ±/± mice was markedly increased compared with the response seen in wild-type mice (Fig. 2B ). As expected, the in¯ammatory responses observed in IL-1Ra ±/± mice given OVA were enhanced (data not shown). These results suggest that IL-1 functions in the development of AHR.
Roles of IL-1 in T h 2 cell activation during AHR
Although IL-1 is thought to promote both T h 1 and T h 2 cellmediated immune responses, the role of IL-1 in T h 2 cell activation during AHR remains poorly understood (15±20). Therefore, we assessed allergen-speci®c T cell responses in IL-1a/b ±/± mice challenged with OVA. The OVA-speci®c T cell proliferative responses of IL-1a/b ±/± mice were profoundly decreased in comparison with those in wild-type mice (Fig. 3A) . The levels of the T h 2 cytokines IL-4 and IL-5 were also reduced in the supernatants of the IL-1a/b ±/± LN cell cultures (Fig. 3B) . In contrast, OVA-speci®c proliferative responses and the production of IL-4 and IL-5 in LN cells increased in IL-1Ra ±/± mice ( Fig. 3C and D) . These results suggest that IL-1 plays an important role in T h 2 cell activation during AHR.
Allergen-speci®c IgG1 and IgE production
The levels of OVA-speci®c IgG1 and IgE in sera were determined by ELISA to assess if reduced T h 2 cell activation affected B cell antibody production in IL-1a/b ±/± mice. OVA-speci®c IgG1 and IgE levels in sera obtained from IL-1a/b ±/± mice were signi®cantly lower than those seen in wild-type mice (Fig. 4A) . Sera from IL-1Ra ±/± mice, however, contained elevated levels of IgG1 and IgE as compared to those from wild-type mice (Fig. 4B ), suggesting that IL-1 is necessary for T h 2 cytokine-dependent antibody production in AHR.
Roles of IL-1a and IL-1b in AHR
To determine whether IL-1a or IL-1b, or both, are involved in the development of AHR, we sensitized IL-1a ±/± and IL-1b ±/± mice with OVA in the absence of adjuvant. The AHR induced 
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Downloaded from https://academic.oup.com/intimm/article-abstract/15/4/483/785272 by guest on 24 December 2018 to methacholine in IL-1a ±/± mice was signi®cantly reduced compared with that of wild-type mice (Fig. 5 ). Such responses in IL-1b ±/± mice were also reduced in a similar fashion to IL-1a ±/± mice (Fig. 5) . These results suggest that both IL-1a and IL-1b are required for AHR development.
We next examined primary OVA-speci®c T cell responses, and found that the levels of proliferation of DO11.10 Tg T cells cultured with the antigen-presenting cells (APC) derived from IL-1a ±/± and IL-1b ±/± mice were partially, but not completely, decreased in the presence of OVA peptide in comparison to the wild-type levels (Fig. 6 ). The levels of OVA-speci®c IgE, but not IgG1, present in the sera of IL-1a ±/± mice were signi®cantly reduced compared with wild-type sera (Fig. 7) . The production of both IgG1 and IgE in response to OVA in IL-1b ±/± mice, however, was lower than that of wild-type mice. Similar observations were noted for the total Ig levels in the sera of non-immunized mice (Fig. 8) . These results suggest that IL-1a and IL-1b have mutually complementary activities in T cell activation, but have differing effects on antibody production.
Discussion
In this study, we demonstrate that AHR is markedly reduced in IL-1a/b ±/± mice, but exacerbated in IL-1Ra ±/± mice, and that both IL-1a and IL-1b are required for this reaction. It was reported that the recruitment of eosinophils into the lungs was markedly reduced in IL-1RI ±/± mice on a 129 Q B6 F 1 background following OVA/alum sensitization (14) . The magnitude of AHR and the number of lung-in®ltrating eosinophils, however, were normal in IL-1a/b ±/± mice on the BALB/cA background using a similar experimental protocol ( Fig. 1 and  data not shown) . Then, in this study, we examined AHR in IL-1a/b ±/± mice on a BALB/cA background using repeated OVA/PBS sensitization without alum. As alum induces excess Fig. 3 . OVA-speci®c T cell responses in IL-1a/b ±/± and IL-1Ra ±/± mice during AHR. The proliferative responses of LN cells derived from OVAchallenged wild-type, IL-1a/b ±/± and IL-1Ra ±/± mice were measured by [ 3 H]thymidine uptake. Twenty-four hours after the ®nal OVA inhalation, submaxillary LN cells were cultured in the absence or presence of 40 mg/ml OVA for 72 h. The averages T SD of triplicate experiments are shown. These results were reproduced in three independent experiments. IL-4 and IL-5 levels in the pooled supernatant of three wells from the proliferative response assay were determined by ELISA. These results were reproduced in three independent experiments. (A) OVA-speci®c proliferative responses, (B) IL-4 and IL-5 levels in wild-type and IL-1a/b ±/± mice, (C) OVA-speci®c proliferative responses, and (D) IL-4 and IL-5 levels in wild-type and IL-1Ra ±/± mice. T h 2 responses even in the absence of IL-4Ra signaling (27) , the presence of alum may account for the differences obtained through the use of either OVA/alum or OVA/PBS. Since many asthmatic patients develop dramatic pathophysiological responses to low-dose allergen challenge (28) , AHR induced by a weak inducer OVA/PBS, not OVA/alum, appears to re¯ect the general pathological predisposition of an individual. This notion is supported by the observation that both B cell-de®cient and mast cell-de®cient mice exhibit normal AHR development when sensitized with OVA/alum (29, 30) . This directly con¯icts with the generally accepted notion that the activation of mast cells via antigen±IgE complexes is crucial for the development of AHR (31) . In contrast, AHR in mast cell-de®cient mice sensitized to OVA without alum was markedly reduced (24) .
IL-1 functions as both a T cell activator and a pro-in¯ammatory cytokine. IL-1±IL-1RI signaling is responsible for the induction of VCAM-1 expression, recruiting eosinophils to the lungs during AHR (14) . On the other hand, we showed that antigen-speci®c T cell proliferative responses, IL-4 and IL-5 production by T cells, and antigen-speci®c IgG1 and IgE secretion by B cells were reduced in IL-1a/b ±/± mice during AHR, whereas these responses increased in IL-1Ra ±/± mice compared with wild-type mice. These results suggest that IL-1 plays an important role in activating T h 2 cells. Consistently with these observations, involvement of IL-1 in T h 2 activation, that is either dependent or independent of IL-4 and requires Lck activation, has been suggested (15, 17, 18) . Furthermore, IL-1 induces OX40 (CD134) expression on CD4 + T cells (26) , that plays an important role in T h 2 cell activation (32) . Interestingly, AHR in OX40 ±/± mice is markedly reduced (33) . Thus, it is suggested that IL-1 functions in AHR through activating T h 2 cells.
IL-1 also potentiates T h 1 cell-mediated immune responses. APC-produced IL-1 induces CD40 ligand (L) (CD154) on CD4 + T cells (26) ; cross-linking of CD40 on APC with CD40L leads to APC production of IL-12, IL-1a/b and TNF-a (34) . These cytokines, including IL-1, all enhance the IL-12dependent production of IFN-g in BALB/c background mice (35) . IL-4 production in IL-1RI ±/± mice infected with Leishmania major increased from that seen in wild-type mice, suggesting IL-1 negatively regulates IL-4 expression (36) . We found that the development of delayed-type hypersensitivity reaction, Fig. 4 . OVA-speci®c IgG1 and IgE levels in sera from IL-1a/b ±/± and IL-1Ra ±/± mice during AHR. Sera were collected 24 h after the ®nal inhalation. OVA-speci®c Ig levels were determined by ELISA. Each circle represents an individual mouse. The average and SD are shown. (A) Wild-type (n = 11) and IL-1a/b ±/± (n = 8) mice. (B) Wildtype (n = 11) and IL-1Ra ±/± (n = 7) mice. *P < 0.005 and **P < 0.01 versus wild-type mice. Fig. 5 . AHR to methacholine in IL-1a ±/± and IL-1b ±/± mice sensitized with OVA without alum. AHR was induced to methacholine in wildtype (squares), IL-1a ±/± (diamonds) and IL-1b ±/± (circles) mice sensitized with either PBS alone (open symbols) or OVA/PBS (closed symbols). Data from two independent experiments are pooled and the averages of each mouse group T SD are shown. *P < 0.01 versus wild-type mice. mediated by T h 1 cells, is signi®cantly suppressed in IL-1a/b ±/± mice on both the BALB/cA and C57BL/6J backgrounds, and that IL-1 is required for antigen-speci®c T h 1 cell activation (Nambu et al., in preparation). Thus, IL-1 is likely involved in both T h 1 and T h 2 cell activation through the induction of the costimulatory molecules, CD40L and OX40, on CD4 + T cells.
We previously demonstrated that IL-1b rather than IL-1a is required for T cell-dependent IgG production (20) . Consistent with this observation, IgG1 production against OVA during AHR was reduced in IL-1b ±/± , but not IL-1a ±/± , mice. The total and OVA-speci®c IgE levels in both IL-1a ±/± and IL-1b ±/± mice, however, were reduced from the levels seen in wild-type mice. Follicular dendritic cells (FDC), which are critical in B cell Ig class switching within germinal centers, express IL-1b, but not IL-1a (37) . This evidence supports the idea that IgG1 and IgE production is reduced in IL-1b ±/± mice, despite a molecular mechanism favoring the reduction of IgE levels in IL-1a ±/± mice. Lymphotoxin (LT)a ±/± mice exhibit a lack of LN and Peyer's patch development, abnormal architecture of the spleen, and germinal center formation failure resulting from defects in the FDC network (38) . In these mutant mice, Ig class switching in response to particle antigens, including sheep red blood cells, does not occur (38) . When treated with repeated immunization with soluble protein antigen with adjuvant, Ig class switching to these antigens occurred normally in LTa ±/± mice despite the absence of germinal centers in the spleen (39) . Thus, Ig class switching can occur independent of the FDC network and germinal center formation under speci®c conditions in which excess cytokines are produced. FDC produce IL-1b, but not IL-1a (37), while T h 2 cells express IL-1a (17) . Although evidence may be lacking, we speculate that IL-1a, derived from T h 2 cells, may have a distinct role in the regulation of IgE production functioning independently from the IL-1b derived from germinal center FDC. Fig. 6 . OVA-speci®c T cell proliferative responses in IL-1a ±/± and IL-1b ±/± mice. The effects of IL-1 on T cell priming were evaluated using DO11.10 Tg T cells and splenic adherent cells from wild-type, IL-1a ±/± , IL-1b ±/± , IL-1a/b ±/± and IL-1Ra ±/± mice. The averages T SD of triplicate experiments are shown. These results were reproduced in three independent experiments. Fig. 7 . OVA-speci®c IgG1 and IgE levels in sera from IL-1a ±/± and IL-1b ±/± mice during AHR. Sera were collected 24 h after the ®nal inhalation. OVA-speci®c Ig levels were determined by ELISA. Both IgG1 and IgE levels speci®c to OVA in IL-1b ±/± mice was low in comparison with the levels of wild-type mice, while IgE production in response to OVA was reduced only in IL-1a ±/± mice. Each circle represents an individual mouse. An average and SD are shown. Wild-type (n = 17), IL-1a ±/± (n = 17) and IL-1b ±/± (n = 17) mice. Fig. 8 . Total IgG1 and IgE levels in sera from non-sensitized IL-1 ±/± mice. Sera were collected from non-sensitized mice. Total IgG1 and IgE levels were determined by ELISA. Total Ig levels from nonsensitized IL-1 ±/± mice showed a similar tendency to OVA-speci®c Ig levels in sensitized mice shown in Fig. 7 . Each circle represents an individual mouse. Averages T SD are shown. Wild-type (n = 11), IL-1a ±/± (n = 12), IL-1b ±/± (n = 6) and IL-1a/b ±/± (n = 8) mice. *P < 0.01 versus wild-type mice.
In summary, we demonstrated that both IL-1a and IL-1b have critical roles in the development of AHR through the activation of T h 2 cells during the sensitization phase. These ®ndings may be useful to develop novel therapeutics to treat asthma.
